Navigation Links
CSL in Medical News

Patient Convenience Focus of New Upgrades to HeliTrax System by CSL Behring

Hemophilia A patients can now record and track treatment progress between office visits wherever Internet access is available. King of Prussia, PA (PRWEB) May 4, 2009 -- Hemophilia A patients and their treatment providers are now better able to manage their condition, t...

Melissa Biggs, Fashion Designer and Former Baywatch Actress, Teams with CSL Behring to Raise Awareness of Alpha-1 Antitrypsin Deficiency, a Commonly Misdiagnosed Respiratory Disease

Biggs Named Spokesperson for Education Campaign on Behalf of CSL Behring, maker of Zemaira(R), Alpha-1 Proteinase Inhibitor (Human) Augmentation Therapy KING OF PRUSSIA, Pa., May 17 /PRNewswire/ -- Melissa Biggs, a fashion designer and actress who appeared on B...

Haemacure Confirms Operation Qualification of Production Equipment and Pursues Milestone Payment from CSL

HAE:TSX MONTREAL, Dec. 4 /PRNewswire-FirstCall/ - Haemacure Corporation (TSX:HAE), a Montreal-based specialty bio-therapeutics company developing high-value, human plasma-derived protein products for commercialization, announces that is has confirmed the successful operation qualification...

U.S. Expects 160 Million Doses of Swine Flu Vaccine by October

...mens will be given three weeks apart. Two manufacturers, Sanofi Pasteur and csl Biotherapies, produced the vaccines. If these trials seem safe, the vacc...rer Vaxine initiated trials Monday with 300 participants, while Melbourne's csl has 240 people in its seven-month study. Australia had 14,703 confirmed cas...

U.S. Swine Flu Vaccine Trials Set to Begin

...mens will be given three weeks apart. Two manufacturers, Sanofi Pasteur and csl Biotherapies, produced the vaccines. If these trials seem safe, the vacc...rer Vaxine initiated trials Monday with 300 participants, while Melbourne's csl has 240 people in its seven-month study. Australia had 14,703 confirmed cas...

NIAID set to launch clinical trials to test 2009 H1N1 influenza vaccine candidates

...ssess whether one or two 30 microgram doses are needed. The doses will be given 21 days apart, testing two manufacturers' vaccines (Sanofi Pasteur and csl Biotherapies). If early information from those trials indicates that these vaccines are safe, similar trials in healthy children (aged 6 months to 17 ...

World's 1st Swine Flu Vaccine Trials Start in Australia

...virus that has so far killed more than 700 people worldwide. Adelaide-based Vaxine initiated trials Monday with 300 participants, while Melbourne's csl has 240 people in its seven-month study. Australia had 14,703 confirmed cases of swine flu as of Wednesday, and at least 41 deaths, according to the ...

FDA Approves Seasonal Flu Vaccine for 2009-2010

...c health problems are at higher risk for flu-related complications. The FDA said the six vaccines for 2009-2010 and the manufacturers are: Afluria, csl Limited; Fluarix, GlaxoSmithKline Biologicals; FluLaval, ID Biomedical Corporation; Fluvirin, Novartis Vaccines and Diagnostics Limited; Fluzone, Sano...

NORD to Honor Rare Disease Pioneers

...first treatment to be approved by the Food and Drug Administration (FDA) for the jerky movements (chorea) associated with Huntington's disease csl Behring, for developing and bringing to market RiaSTAP(TM), the first and only treatment for acute bleeding episodes in patients with congenital fibri...

The American Partnership for Eosinophilic Disorders (APFED) Honors Disney Star Demi Lovato and the Jonas Group's Ned Specktor, as 2009-2010 Honorary Ambassadors of Education

...isit www.apfed.org . APFED Premier Gala to Honor Demi Lovato and Ned Specktor Sponsored by Abbott Laboratories, Ception Therapeutics, csl Behring, and Meritage Pharma, Inc. Monday, May 11, 2009 6:00 p.m. Cocktails 7:00 p.m. Dinner 9:30 p.m. Awards Mon...
CSL in Medical Technology

Over $10 Million of CSL Behring's Privigen Was Sold in the U.S. During the Third Quarter of 2008

MALVERN, Pa., Nov. 18 /PRNewswire/ -- Arlington Medical Resources (AMR), a provider of premier market intelligence for the pharmaceutical and diagnostic imaging industries, finds that over $10 million of CSL Behring's Privigen was sold in the U.S. during the third quarter of 2008. Privigen is the ...

Celltrion and CSL Announce Collaboration to Develop and Manufacture Monoclonal Antibody

INCHEON, South Korea, Jan. 10 /PRNewswire/ -- Celltrion, Inc., a Korean biopharmaceutical company whose core business is currently contract manufacturing, and CSL Limited, Australia's leading biopharmaceutical company, announced today the signing of an agreement for the development and supply ...

CSL Behring Receives Orphan-Drug Exclusivity for RiaSTAP(TM), First and Only Approved Treatment of Acute Bleeding Episodes in Patients with Congenital Fibrinogen Deficiency

... KING OF PRUSSIA, Pa., March 11 /PRNewswire/ -- csl Behring has been informed by the U.S. Food and Dru...fe, effective and high-quality biologic therapies, csl Behring is committed to meeting the needs of patie..." said Paul Perreault, Executive Vice President of csl Behring's Worldwide Commercial Operations. "As the...

CSL Behring Submits BLA Requesting Approval of C1-Esterase Inhibitor for the Treatment of Hereditary Angioedema

...ks KING OF PRUSSIA, Pa., March 6 /PRNewswire/ -- csl Behring has submitted a biologics license applicat...merica. "Submission of the BLA for C1-INH brings csl Behring one step closer to providing therapy for h...nior Vice President of Research and Development at csl Behring. "We are confident that our expertise in d...

CSL Behring Study in Animal Models Shows Feasibility of Developing a Half-Life Extended Recombinant FVIIa that Retains Biologic Activity

...with inhibitors ATLANTA, Dec. 10 /PRNewswire/ -- csl Behring today announced the results of a pre-clini...l interventions." Recombinant VIIa-FP represents csl Behring's initial corporate foray into research wi...r. Andrew Cuthbertson, Chief Scientific Officer at csl Ltd., parent company of CSL Behring. "By increasin...

Preclinical Studies Show Promise for Novel Antibody Therapy to Treat Acute Myeloid Leukemia (AML)

...emic stem cells ATLANTA, Dec. 10 /PRNewswire/ -- csl Limited, Australia's leading biopharmaceutical com...g new option for the treatment of AML," he said. csl wishes to acknowledge the contribution of the Univ... 414 769 194 Dr. Darryl Maher Medical Director csl Bioplasma Phone: +61 412 346 987 Media Contact ...

CSL Behring Reaches Primary Endpoint in Clinical Study of C1-INH for Treatment of Hereditary Angioedema

... KING OF PRUSSIA, Pa., Nov. 26 /PRNewswire/ -- csl Behring announced today that it has reached the pr...t HAE, visit http://www.allabouthae.com . About csl Behring csl Behring is a global leader in the plasma protein b...

MedImmune Initiates First Clinical Trial of Monoclonal Antibody Targeting GM-CSFR in Patients with Rheumatoid Arthritis

...ve, worldwide rights to develop and market CAM-3001 under an agreement with csl Limited. "Commencing this trial demonstrates that researchers at MedImmun... the terms of a subsequent licensing agreement entered into in August 2007, csl will receive upfront and milestone payments, as well as royalties, on futur...

Study Shows Need to Test More COPD and Asthma Patients for Underdiagnosed Pulmonary Disease

...of people with the deficiency remain undiagnosed. csl Behring to Launch National Campaign to Improve Det... series Today's Health. For more information, call csl Behring Consumer Affairs at 1-866-936-2472, or visit http://www.testtodaychangetomorrow.com . csl Behring is the maker of Alpha1-Proteinase Inhibito...

Seriously Low Vaccination Rates Cause Experts to Call for Increased Immunization Before Influenza Season Peaks

...y the Centers for Disease Control and Prevention, and through unrestricted educational grants to NFID by the Centers for Medicare & Medicaid Services, csl Biotherapies, Flu Vaccine Business Practices Initiative (c/o HIDA), GlaxoSmithKline, Henry Schein, Inc., MedImmune Vaccines, Merck and Co., Inc., Nova...
CSL in Biological News

TECNALIA uses artificial vision to improve recycling of electronic scrap metal

...from Tecnalia, taking part in this project are the csl technological centre at the University of Lige (B...e samples were carried out by the designers of the csl illumination system, by means of point to point an...arately. The system of illumination proposed by csl is a new design the aim of which is to achieve uni...
CSL in Biological Technology

Video: CSL Behring Provides $1.2M Grant for World's First Study of Postpartum Women with VWD, Common Bleeding Disorder

Goal is to determine whether therapy after childbirth for women with von Willebrand disease is needed and for how long KING OF PRUSSIA, Pa., Aug. 18 /PRNewswire/ -- CSL Behring is providing a $1.2 million grant to fund a first-of-its kind, nationwide study that when completed could...

WEHI Spin-Out MuriGen Restructures G-CSF Antagonist Program With CSL

MELBOURNE, Australia, Oct. 27 /PRNewswire/ -- MuriGen Therapeutics today announced that its collaboration with CSL for the development of a new class of drugs that target arthritis and other inflammatory diseases has been restructured. The collaboration was initially established in February ...

CSL Limited and Talecris Biotherapeutics Agree to Terminate Merger Agreement

...SEARCH TRIANGLE PARK, N.C., June 8 /PRNewswire/ -- csl Limited (ASX: CSL) and Talecris Biotherapeutics, I...reement, announced on August 12, 2008, under which csl agreed to acquire Talecris for US$3.1 billion in c... Dr. Brian McNamee, CEO and Managing Director of csl Limited, said, "We are disappointed that the U.S. ...

CBDM.T, The Market and Business Intelligence Company Reviews The Vaccine Market

... comments Philippe Tramoy, managing partner. Key players: Sanofi-Aventis, Sanofi-Pasteur, GSK, Wyeth, Merck, Norvartis, Chiron, Avax Technologies, csl Biotherapies, Omrix biopharmaceuticals, Epimmune, Oxxon Therapeutics, Vical, Fit Biotech, Genencor, Innogenetics. If you need market and business...

Novavax and Vivalis Sign a Research License Agreement to Use the EB66(R) Cell Line for the Production of Virus Like Particle Based Vaccines

...ovax, Merial, Intervet-Schering Plough or Virbac and has already been licensed to 4 companies for the production of proteins including Sanofi-Aventis, csl limited and Innate Pharma. With a portfolio of 23 licenses (10 research licenses and 13 commercial licenses), the EB66(R) cell line is becoming a new ...

Australian Authorities (TGA) First to Grant Final Product Approval for Intercell's Vaccine to Prevent Japanese Encephalitis

...squitoes. Intercell's vaccine will be the only registered JE-vaccine available in the Australian market and will be distributed and marketed by csl Biotherapies Pty Ltd., which has the exclusive right for marketing and distribution of the novel cell culture-based vaccine in Australia, New Zealand,...

MedImmune Licenses Reverse Genetics Technology to Hungary's Omninvest for Use in Influenza Vaccine Development and Production

...attenuated nasal spray influenza vaccine for the 2008-2009 season. Since December of 2006, MedImmune has licensed its reverse genetics technology to csl Limited of Australia, sanofi pasteur, Novartis, GlaxoSmithKline and BIKEN of Japan. About MedImmune MedImmune is a leading innovation-focused biot...

Video: Moms Raise 'Red Flag' About the Dangers of Widely Undiagnosed Bleeding Disorder

..., and it is supported by an educational grant from csl Behring. "Von Willebrand disease is a serious he...ndation visit http://www.hemophilia.org . About csl Behring csl Behring is a global leader in the plasma protein b...

CSL Behring's Innovative HeliTrax(SM) System Helps Physicians Manage Hemophilia A Patients

...ased data management system recently introduced by csl Behring. The system allows for a comprehensive vie...uring that the patient's complete record is saved. csl Behring has no access to patient data and all data...n M.D., Senior Director of U.S. Medical Affairs at csl Behring. "CSL Behring is committed to the bleeding...

CSL Behring Signs Agreements With Canadian Blood Services and Hema-Quebec to Supply Life-Saving Therapies

... Disorders OTTAWA, April 3, 2008 /PRNewswire/ -- csl Behring Canada, Inc. today announced that Canadian...other serious conditions. The contracts call for csl Behring to supply the above mentioned life-saving ...g disorder treatments in the province of Quebec. csl Behring currently maintains a portfolio of 23 diff...
Other Tags
(Date:8/1/2014)... August 01, 2014 The American ... Gregg Harper (R-MS), and Peter Welch (D-VT), for ... Medicare Telehealth Parity Act of 2014, which improves ... this effort to improve healthcare access and affordability ... officer of ATA. "These cost-saving provisions are critical ...
(Date:8/1/2014)... On Monday, June 30th, the Quirk ... in San Francisco, CA. Now in its fourth year, ... Union Square hotel. , “We are excited about returning ... with ACA compliance issues,” Quirk Healthcare Foundation Executive Director, ... attendees guidance with NextGen implementation and use, electronic records ...
(Date:8/1/2014)... FRIDAY, Aug. 1, 2014 (HealthDay News) -- Although many parents ... many overlook a common choking hazard: food. Such ... wheeze and cough after eating a handful of nuts. ... not obvious if the coughing was related to his illness ... wasn,t a cold. A cashew had become lodged in his ...
(Date:8/1/2014)... 01, 2014 Over the past ... from innovative technologies that have enabled cosmetic dentists ... tooth color. Moreover, the burgeoning elderly population has ... tooth ailments. Due to long-term use of medications, ... have demanded dental fillings, veneers and implants. As ...
(Date:8/1/2014)... Oxford Gene Technology (OGT) is ... products include CytoSure heamatological cancer +SNP Array, CytoSure ... UPD array, CytoSure ISCA sample tracking spike-ins and ... such as targeted sequencing services, SureSeq Solid Tumour ... expression analysis, cytosure services and aCGH for CNV ...
Breaking Medicine News(10 mins):Health News:ATA Applauds Bill on Medicare Telemedicine Improvements 2Health News:Quirk Healthcare Foundation Hosts Fifth Annual California NextGen User Symposium and Launches First Annual Florida NextGen User Symposium 2Health News:Food Is a Common Choking Hazard for Kids, Doctor Says 2Health News:Cosmetic Dentists in the US Industry Market Research Report from IBISWorld Has Been Updated 2Health News:Cosmetic Dentists in the US Industry Market Research Report from IBISWorld Has Been Updated 3Health News:Oxford Gene Technology Market Size, Share, Analysis, Trends and Forecasts 2014 2Health News:Oxford Gene Technology Market Size, Share, Analysis, Trends and Forecasts 2014 3
(Date:8/1/2014)... One of the most diverse families in the ... (or lucinids) -- originated more than 400 million years ... habits like those of its modern members. This ... of Hawaii, published online on 25 July 2014, tracks ... symbiotic relationships. , At is origin, the Lucinidae family ...
(Date:8/1/2014)... new study, including two Simon Fraser University research ... and policymakers must collaborate closely on minimizing damage ... Viorel Popescu and Maureen Ryan, David H. Smith ... are among eight international co-authors of the newly ... the Environment . , Shale gas development is ...
(Date:7/31/2014)... research, supported by the National Science Foundation (NSF), ... uniformly accelerates atmospheric warming, indicating instead that certain ... emit into the atmosphere. , The study, ... , focuses on thermokarst lakes, which occur as ... with melted fresh water, converting what was previously ...
Breaking Biology News(10 mins):Symbiotic survival 2Symbiotic survival 3Symbiotic survival 4Symbiotic survival 5Symbiotic survival 6Symbiotic survival 7Symbiotic survival 8Symbiotic survival 9Symbiotic survival 10Symbiotic survival 11Symbiotic survival 12Symbiotic survival 13Symbiotic survival 14Scientists warn time to stop drilling in the dark 2Scientists warn time to stop drilling in the dark 3Certain Arctic lakes store more greenhouse gases than they release 2
Other Contents